Robert W. Baird Forecasts Strong Price Appreciation for Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group (NASDAQ:PRVA - Free Report) had its price target boosted by Robert W. Baird from $24.00 to $26.00 in a research report released on Tuesday, Marketbeat Ratings reports. Robert W. Baird currently has an outperform rating on the stock.

Several other research analysts also recently issued reports on PRVA. Piper Sandler upped their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. Truist Financial increased their target price on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. Stephens reaffirmed an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. Barclays increased their price objective on Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a research report on Thursday, April 10th. Finally, Canaccord Genuity Group upped their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $27.00.

Privia Health Group Stock Down 0.8 %

Shares of NASDAQ PRVA traded down $0.19 during trading on Tuesday, reaching $23.68. The company had a trading volume of 845,501 shares, compared to its average volume of 781,804. The business's 50-day moving average is $23.82 and its 200 day moving average is $21.70. The stock has a market cap of $2.87 billion, a PE ratio of 236.82, a P/E/G ratio of 3.47 and a beta of 0.88. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $26.04.

Insiders Place Their Bets

In related news, CFO David Mountcastle sold 5,630 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the transaction, the chief financial officer now owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 10.70% of the company's stock.

Hedge Funds Weigh In On Privia Health Group

Large investors have recently made changes to their positions in the business. Riverbridge Partners LLC raised its stake in Privia Health Group by 19.7% during the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock valued at $113,868,000 after purchasing an additional 958,418 shares during the period. Loomis Sayles & Co. L P lifted its holdings in shares of Privia Health Group by 55.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after buying an additional 503,002 shares in the last quarter. Durable Capital Partners LP boosted its position in shares of Privia Health Group by 3.4% during the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock worth $224,587,000 after acquiring an additional 378,255 shares during the last quarter. BlackBarn Capital Partners LP grew its stake in Privia Health Group by 65.8% during the fourth quarter. BlackBarn Capital Partners LP now owns 663,397 shares of the company's stock valued at $12,969,000 after acquiring an additional 263,397 shares in the last quarter. Finally, Nuveen Asset Management LLC increased its holdings in Privia Health Group by 19.8% in the 4th quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock valued at $29,110,000 after acquiring an additional 246,393 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.